This funding opportunity supports early-stage projects proposing proof-of-concept or pilot studies to develop innovative technologies for cancer research and clinical care. It emphasizes high technical innovation with potential to accelerate research in cancer biology, detection, diagnosis, treatment, control, and epidemiology. Technologies may include molecular analysis platforms, imaging, immuno-engineering, and biospecimen processing focused on cancer applications.
Eligible applicants include a wide range of government entities, educational institutions, nonprofits, for-profit organizations, small businesses, tribal governments, and foreign institutions. Specific eligibility details are provided in the full announcement.
